awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q24624083-B8DF9DF6-6F59-436D-879C-5DC818D406FF
Q24624083-B8DF9DF6-6F59-436D-879C-5DC818D406FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24624083-B8DF9DF6-6F59-436D-879C-5DC818D406FF
Crizotinib: A comprehensive review
P2860
Q24624083-B8DF9DF6-6F59-436D-879C-5DC818D406FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24624083-B8DF9DF6-6F59-436D-879C-5DC818D406FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ceb196296e248283415503e786ab2b37f5b602b1
P2860
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)